SMARCA4 and neoplasm: We observed that Ccnd1 was expressed in 13.9% of Brg1-negative tumor cells and was expressed in 72.7% of Brg1-positive tumor cells; this difference was statistically significant (p=4.0E-7) (Figure 3B).